(Q40565443)

21 September 2017

The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells (English)

1 reference

21 September 2017

1 reference

Roxane Engel

1

1 reference

21 September 2017

Nikola I Valkov

2

1 reference

21 September 2017

Jana L Gump

3

1 reference

21 September 2017

Lori Hazlehurst

4

1 reference

21 September 2017

William S Dalton

5

1 reference

21 September 2017

Daniel M Sullivan

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Experimental Cell Research

21 September 2017

1 reference

21 September 2017

295

1 reference

21 September 2017

2

1 reference

21 September 2017

421-431

1 reference

DNA topoisomerases: structure, function, and mechanism

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Cellular roles of dna topoisomerases: a molecular perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Investigating the biological functions of DNA topoisomerases in eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Topoisomerase II: A specific marker for cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Clinical applications of anticancer drugs targeted to topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

The role of drug efflux pumps in acute myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Cell density-dependent VP-16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIalpha from the nucleus to the cytoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Ectopic expression of human topoisomerase IIalpha fragments and etoposide resistance in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Proliferation dependence of topoisomerase II mediated drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

The comet moment as a measure of DNA damage in the comet assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T1/2) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Leptomycins A and B, new antifungal antibiotics. III. Mode of action of leptomycin B on Schizosaccharomyces pombe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase II alpha associated with nuclear matrices from wild-type and drug-resistant chinese hamster ovary cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

The cytochrome b5 tail anchors and stabilizes subdomains of human DNA topoisomerase II alpha in the cytoplasm of retrovirally infected mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.01.012

10.1016/J.YEXCR.2004.01.012

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference